Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00627016 · ClinicalTrials.gov registry record · Phase 3

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

A Phase 3 study of Gastroesophageal Reflux, sponsored by Takeda.

Completed
Registry status
Phase 3
Development phase
305
Enrollment target
20
Study locations

NCT00627016 is a Phase 3 study of Gastroesophageal Reflux that has completed, run by Takeda. The registered enrollment target is 305 participants, above the 173-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (76% higher). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00627016, a Phase 3 study of Gastroesophageal Reflux, has completed, sponsored by Takeda.

COMPLETED
Registry status
Phase 3
Development phase
305 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine whether Dexlansoprazole once daily (QD) is effective in treating patients with night heartburn.

Conditions Studied

Gastroesophageal Reflux

Interventions

  • DRUG Placebo
  • DRUG Dexlansoprazole

Study Locations (20)

California

  • - Anaheim
  • - Garden Grove
  • - Lancaster
  • - Oakland
  • - San Diego
  • - Sherwood
  • - Westlake Village

Florida

  • - Jupiter
  • - Miami
  • - New Smyrna Beach
  • - Ocala
  • - St. Petersburg
  • - Zephyrhills

Arizona

  • - Tucson

Illinois

  • - Moline

Iowa

  • - Clive

Kansas

  • - Wichita

Louisiana

  • - Metairie

Maryland

  • - Prince Frederick

Trial Details

FieldValue
Enrollment Target 305 participants
Start Date 2008-03
Est. Completion 2009-03
Phase Phase 3

Sponsor

Takeda

408 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00627016

The ClinicalTrials.gov registry entry for NCT00627016 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 173-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (76% higher). The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00627016 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Arizona.

Frequently Asked Questions

What is clinical trial NCT00627016 about?

NCT00627016 is a clinical study titled "A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn". The purpose of this study is to determine whether Dexlansoprazole once daily (QD) is effective in treating patients with night heartburn.

What is the current status of trial NCT00627016?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 305 participants. The study started on 2008-03. Estimated completion is 2009-03.

What conditions does trial NCT00627016 study?

This clinical trial studies the following conditions: Gastroesophageal Reflux.

What interventions are being tested in trial NCT00627016?

The interventions under investigation include: Placebo (DRUG), Dexlansoprazole (DRUG).

Who is sponsoring clinical trial NCT00627016?

This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00627016 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gastroesophageal Reflux

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gastroesophageal Reflux

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.